ERNEST ECKENRODE: Open Payments
NPI 1659049526 · HUNT VALLEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 152 payments from 19 companies in 2025. Trend: 2023 $1,935 · 2024 $2,663 · 2025 $2,944
Food & beverage: $2,844Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $376 |
| UCB, Inc. | 18 | $370 |
| Janssen Biotech, Inc. | 17 | $369 |
| Regeneron Healthcare Solutions, Inc. | 14 | $354 |
| Novartis Pharmaceuticals Corporation | 17 | $239 |
| ABBVIE INC. | 18 | $237 |
| GENZYME CORPORATION | 7 | $215 |
| PFIZER INC. | 13 | $191 |
| Galderma Laboratories, L.P. | 10 | $182 |
| E.R. Squibb & Sons, L.L.C. | 9 | $137 |
Products named: DUPIXENT, Bimzelx, TREMFYA, CIBINQO, COSENTYX, ILUMYA, NEMLUVIO, Sotyktu.
Industry payments across MD — which companies pay providers there.
